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Objective 
To compare simultaneous and 2-stage surgical implantation of an artificial urinary sphincter (AUS) 
and penile prosthesis (PP) for patients with severe urinary incontinence and erectile dysfunction 
after prostatectomy. 
Methods 
The data from 23 patients were reviewed, 15 (group 1) underwent simultaneous implantation and 
8 (group 2) underwent 2-stage surgery. The operative time, complications, postoperative pain, 
incidence of pre- and postoperative urinary incontinence, erectile dysfunction rating (International 
Consultation on Incontinence questionnaire, Incontinence Quality of Life, International Index of 
Erectile Function, and Erectile Dysfunction Inventory of Treatment Satisfaction), and patient 
satisfaction were evaluated. 
Results 
The mean operative time was 140 minutes for the simultaneous procedure (group 1) and 105 
minutes for AUS placement and 65 minutes for PP placement (group 2). No major postoperative 
complications were recorded. The average postoperative hospital stay was 2.5 days after the 
double-implant procedure and 2.4 days after AUS and 1.2 days after PP placement. The visual 
analog scale score at 6 and 24 hours after surgery was 5 and 3 in group 1, and 4 and 3 after AUS 
and 3 and 2 after PP (group 2; P > .05). At 1 year, all patients were socially continent, with an 
average International Consultation on Incontinence score of 2 in group 1 and 2 in group 2. Of the 
patients in groups 1 and 2, 65% and 68% were completely dry, respectively (P > .05). The 
Incontinence Quality of Life score increased from 37 to 84 in group 1 and from 41 to 82 in group 2. 
The Patient Global Impression of Improvement revealed that 92% of group 1 and 95% of group 2 
experienced “great improvement” (P > .05). The International Index of Erectile Function and 
Erectile Dysfunction Inventory of Treatment Satisfaction score was 70 of 75 and 87 of 100 in group 
1 and 72 of 75 and 86 of 100 in group 2, respectively (P > .05). Group 1 patients were completely 




AUS and PP synchronous placement is feasible and safe and as effective as the 2-stage procedure, 
with better acceptance by patients. 
Urinary incontinence (UI) and erectile dysfunction (ED) are the most frequent complications 
affecting the prostatectomy outcome. The treatment of patients affected by both UI and ED is a 
major urologic problem. The therapy of choice is implantation of an artificial urinary sphincter 
(AUS) for UI and a penile prosthesis (PP) for ED in selected patients not responding to, or not 
candidates for, other medical or surgical procedures. 
Many investigators have documented the safety, effectiveness, and patient satisfaction for single 
implantation of an AUS or a PP, with excellent results.1, 2 and 3 In 2003, Wilson et al4 introduced 
the possibility of performing implantation of an AUS using a single trans-scrotal incision with 
satisfactory results. Their clinical trial paved the way for simultaneous dual implantation of the 
AUS and PP through the same scrotal incision. 
Few available published studies have demonstrated the feasibility, safety, and cost-effectiveness 
of dual implantation. Moreover, few have reported encouraging outcomes in functional results 
and patient satisfaction level.5, 6 and 7 No studies comparing synchronous and delayed 
implantations of the 2 devices are available. 
Our aim was to report our single-center experience comparing simultaneous and 2-stage surgical 
correction of UI and ED in terms of the surgical feasibility, complications, outcomes, and patient 
satisfaction. 
 
Material and Methods 
We retrospectively reviewed the clinical and surgical documentation of 23 patients (average age 
59 years) who had undergone retropubic radical prostatectomy. From January 2005 to February 
2011, these same 23 patients sought treatment of severe UI due to sphincter damage and severe 
ED, not responsive to phosphodiesterase type 5 inhibitors and not responsive or negatively 
responsive to intracavernous injection therapy. The preoperative evaluation included cystoscopy 
and urodynamic studies. Cystoscopy was used to ascertain the patency of the urethra and bladder-
urethral anastomosis. 
UI was assessed preoperatively using the International Consultation on Incontinence (ICI) 
Questionnaire-Urinary Incontinence Short Form,”8 the Incontinence Quality of Life (I-QoL),9 and 
“social continence” (defined in our study as the use of no pads or ≤1 pad/d). The term “social 
continence” can be defined as the use of 0, 1, or 2 pads daily, depending on the investigators, but 
most consider ≤1 pad/d to indicate continence.10 and 11 
 
Sexual dysfunction was determined before surgery using a psychosexual assessment, the 
International Index of Erectile Function (IIEF), and dynamic Doppler ultrasonography. Sexual 
dysfunction was assessed 6 months after implantation of the PP using the IIEF and Erectile 
Dysfunction Inventory of Treatment Satisfaction. 
Of the 25 patients, 15 (group 1) underwent simultaneous placement of the AUS and PP (10 
patients chose a noninflatable PP and 5 preferred an inflatable PP), and 8 (group 2) underwent 
deferred surgical correction of UI and ED. Group 2 first underwent implantation of an AUS for 
severe UI and, in the second stage, underwent implantation of a nonhydraulic malleable PP. The 
average period between the first and second procedure was 15 months. AUS/PP implantation 
surgery was performed 10 months (range 8-13) after radical retropubic prostatectomy in both 
groups. 
In the presence of both severe UI and ED, our policy was first to treat the main complaint of the 
patient, typically the UI. Subsequently, many patients, satisfied by their great improvement in 
terms of continence, exhorted us to solve their sexual dysfunction and, accordingly, underwent PP 
implantation. During the same period, 3 other patients were treated. These patients were affected 
by severe ED and mild or very mild UI and considered sexual impotence to be their main problem 
after prostatectomy. Thus, as the first procedure, these patients requested PP placement and as 
the second procedure, AUS implantation. One of these patients underwent concomitant PP and 
sling implantation, reported unsatisfactory improvement of the UI 13 months after surgery. Two 
other patients experienced an aggravation of UI, 1 year after PP implantation, because of 
endoscopic revision of the bladder-urethral anastomosis necessary to treat a stenosis. However, 
the deferred surgical procedure was easily feasible with no significant difficulties with AUS 
implantation in patients already having a PP or sling. However, we decided not to include this 
group of patients because it was not statistically relevant owing to the poor number of cases 
reported. 
Considering the number of patients subsequently undergoing the 2 individual procedures, in 
accordance with previous data reports,4, 5, 6 and 7 we changed our policy by proposing 
synchronous PP and AUS implantation in patients affected by both ED and UI. 
Considering the preoperative severity of incontinence in our patients, AUS implantation was 
preferred to a sling, as mentioned in the European Association of Urology guidelines.12 The AMS 
800 double-cuff artificial urinary sphincter was implanted in all cases. In all our surgical 
procedures, an AMS CX 700 was used as a hydraulic PP, and a Subrini Virilis II and an AMS Spectra 
were implanted as noninflatable PP in 15 and 3 cases, respectively. 
Both synchronous implantation of the PP and AUS and implantation of the AUS, as an individual 
procedure, were performed with the same single transversal scrotal incision. In all procedures, the 
reservoir of the AUS was located intraperitoneally by a second, small pararectal incision. The 
reservoir of the hydraulic penile implants was always located extraperitoneally, in the retropubic 
space, by a single penoscrotal incision, in accordance with the technique of Wilson et al.4 All 
patients were extensively informed about the procedures and provided written informed consent 
for AUS and/or PP implantation. 
Postoperative pain was rated using a visual analog score at 6 and 24 hours after each surgical 
procedure. All patients were evaluated at the 12-month routine follow-up visit after synchronous 
implantation (group 1) and after the second surgical procedure in group 2. UI was assessed 
postoperatively using the ICI questionnaire,8 I-QoL,9 and Patient Global Impression of 
Improvement.13 Postoperative “social continence” was also rated. ED was evaluated using the IIEF 
questionnaire. Patient satisfaction with PP implantation was assessed using the Erectile 
Dysfunction Inventory of Treatment Satisfaction questionnaire. 
The data from the 2 groups was statistically analyzed using the SPSS statistical program with the 
Wilcoxon and chi-square tests. 
 
Results 
The average operative time for the double implantation group (group 1) was 140 minutes. The 
average operative time was 155 minutes (range 140-180) to implant an inflatable PP and 130 
minutes (range 120-150) to implant a malleable PP. In group 2, the average operative time was 
105 minutes (range 95-120) for the AUS and 65 minutes (range 60-80) for the PP (all were 
nonhydraulic implants).  
No major intraoperative complications (ie, bleeding, urethral injury, apex or crura perforation) 
were recorded in either group. 
In group 1, the average postoperative hospital stay was 2.5 days. In group 2, the average 
postoperative stay was 2.4 days after AUS implantation and 1.2 days after PP implantation. We did 
not find any statistically significant differences in the postoperative hospital stay between the 2 
groups. 
The average postoperative pain as assessed using the visual analog scale at 6 and 24 hours 
postoperatively was 5 and 3 in group 1 and 4 and 3 after AUS and 3 and 2 after PP implantation in 
group 2, respectively. The difference in the subjective assessment of pain using the visual analog 
scale between the 2 groups was not statistically significant (P > .05). 
The average preoperative ICI score was 20 (range 14-21) in group 1 and 18 (range 17-20) in group 
2. At the 1-year postoperative follow-up visit, all patients were socially continent, with an average 
ICI score of 2 (range 1-5) in group 1 and 2 (range 1-4) in group 2. Moreover, 65% and 68% of 
patients were completely dry in groups 1 and 2, with no significant difference between the 2 
groups (P > .05). 
The average preoperative I-QoL score was 37 (range 27-51) in group 1 and 41 (range 31-55) in 
group 2 (P = .243). At 1 year after surgery, the postoperative I-QoL score was 84 (range 72-89) in 
group 1 and 82 (range 69-88) in group 2, with no meaningful difference between the 2 groups (P = 
.533). 
Our data have suggested that the results in terms of improvement of quality of life are not 
significantly different whether the UI and ED devices were surgically placed in a simultaneous 
procedure or a 2-stage procedure. 
On the PGI-I, the patients reported experiencing “great improvement” in 92% in group 1 and 95% 
in group 2 at 3 months after surgery. The difference was not statistically significant (P > .05). The 
remaining 8% of patients in group 1 and 5% in group 2 considered themselves to have significant 
improvement (P > .05). 
All patients reported excellent sexual improvement. The IIEF (all domains) and Erectile Dysfunction 
Inventory of Treatment Satisfaction score was 70 of 75 and 87 of 100 in group 1 and 72 of 75 and 
86 of 100 in group 2, respectively, with no statistically significant differences (P > .05) between the 
2 groups. 
All group 1 patients were completely satisfied with the single procedure for both their UI and their 
ED. All patients in group 2 would have chosen a single procedure for correction of both problems if 
asked again. 
One patient in group 1, who had previously undergone salvage external beam radiotherapy for 
local recurrence of prostate cancer, experienced a sphincter infection after 2 urethrotomies 
performed for recurrent urethral stricture. The 2 devices were surgically removed 1.5 years after 
dual implantation (grade IIIa). No major postoperative complications were detected in group 2. 
 
Comment 
Some investigators have defined the goals of radical prostatectomy as a “trifecta,” including in the 
definition long-term cancer control and recovery of sexual and urinary function. Although the 
incidence of ED and UI has generally decreased, they remain the most defying long-term 
complications of radical prostatectomy.14, 15, 16 and 17 Prosthetic surgery can effectively treat 
both conditions and represents an additional chance to obtain the trifecta.18 
Currently, the placement of a PP is widely considered an effective and safe procedure to regain 
sexual satisfaction in patients with iatrogenic erectile dysfunction not responding to medical 
therapy or for patients or unwilling to use medical therapy.1, 2 and 19 
The management of UI is more controversial.2, 20 and 21 The European Association of Urology 
Guidelines12 consider AUS placement, after a period of conservative management of 6-12 
months, as the treatment of choice and the reference standard for intermediate to severe 
postprostatectomy UI. In contrast, the male sling, considered by some investigators as a 
satisfactory treatment of postprostatectomy UI,22 and 23 has been deemed by the European 
Association of Urology guidelines as an alternative exclusively for mild to moderate UI. 
 The urinary sphincter has been widely used to treat UI after prostatectomy, with a satisfaction 
rate of ≤90% and total continence rates of approximately 30%.3, 4 and 24 
In 1993, Brito et al25 proposed the placement of a second cuff to achieve better outcomes in 
social continence with excellent results. In a recent report, O'Connor et al26 compared single 
versus double-cuff AUS implantation, with a significantly greater rate of complete continence and 
improvement in the Incontinence Impact Questionnaire 7 in men with the double-cuff AUS 
compared with single-cuff devices. Placing a double-cuff AUS is safe and effective in the treatment 
of severe postprostatectomy UI,27 with only a slight increase in the operative time. This procedure 
is standard in our center. 
The main unsolved problem regarding the management of both ED and UI after prostatectomy is 
whether it is better to treat both conditions in a single surgical procedure or in a 2-stage fashion. 
Some investigators have suggested treating UI and ED using sling implantation and a PP. In 2005, 
Rhee28 described a technique for concomitant implantation of an inflatable and semirigid PP with 
the synthetic male sling, with a high rate of patient satisfaction. Gorbatiy et al29 recently 
proposed synchronous implantation of an inflatable PP and a bulbourethral sling using a single 
perineal incision, with satisfactory results. 
In 2003, Wilson et al4 reported, for the first time, on AUS placement through a single upper scrotal 
incision, with good access to the bulbar urethra and the retropubic and subdartos spaces and 
satisfactory results. Scrotal access paved the way toward synchronous implantation of an AUS and 
a PP. 
In 2008, Henry et al30 evaluated in a retrospective study the differences in terms of continence 
between the traditional perineal and trans-scrotal approaches. Henry et al30 argued that when an 
AUS cuff is placed through a perineal approach, a greater completely dry rate and fewer 
subsequent tandem-cuff additions would be registered compared with the trans-scrotal approach. 
Some investigators have tested synchronous prosthetic treatment of male UI and ED with an AUS 
and a PP, with satisfactory results. Sellers et al5 showed that synchronous double implantation 
significantly reduced the operative time and was associated with cost savings of approximately at 
$7000 compared with the 2 procedures performed separately. Kendirci et al6 reported on the 
safety and the effectiveness of dual implantation compared with single implantation in a series of 
22 patients, with an average follow-up of 17 months. Their intermediate follow-up results were 
favorable. According to their report, the inherent advantage of a single anesthetic event and a 
single trans-scrotal incision should encourage widespread acceptance of this technique. In 2008, 
Mancini7 reported that the dual implantation produces encouraging outcomes in the patient's 
satisfaction level and it provides excellent functional results, similar to the placement of a single 
device alone. 
 
The synchronous placement of the 2 devices does not present with particular surgical difficulties. 
As expected, a slightly longer operative time results when positioning an inflatable PP but always 
within the times considered safe regarding the risk of infection. The postoperative pain was only 
slightly greater 6 hours after double implantation compared with AUS implantation alone, and the 
average visual analog scale score was the same after 24 hours. 
The incidence of surgical site and prosthesis infections and other complications did not increase. 
The only case of late (1.5 years) infection of the AUS occurred after an endoscopic procedure in a 
patient in group 1, and it did not seem likely that is was related to the concomitant placement of 
the 2 devices. 
The functional results at 1 year of follow-up in social/complete continence and as evaluated by 
validated questionnaires do not show statistically significant differences between the single-stage 
and 2-stage procedures. Moreover, when asked, our patients preferred the single-stage surgery 
for the correction of both problems. Even the patients who had undergone a 2-stage procedure, 
when interviewed, would have preferred the single procedure with double implantation. 
Conclusion 
Our data suggest that dual implantation of a PP and an AUS does not result in a greater incidence 
of intra- or postoperative complications, is well tolerated, has the same long-term functional 
outcomes of traditional 2-stage surgery, and, furthermore, is much preferred by the patient. PP 
and AUS synchronous placement is a safe, highly satisfactory, and cost-effective surgery to treat 
patients affected by both ED and severe UI after radical prostatectomy, allowing the avoidance of 
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